This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Rigmor Møller, MD; Jette Howitz, MD
Copenhagen

Arch Dermatol. 1976;112(11):1613-1614.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Serious adverse effects caused by treatment of vitiligo with methoxsalen and ultraviolet (UV) radiation have not, to our knowledge, been reported. However, skin cancer and ocular damage may develop in animals during treatment with methoxsalen and UV radiation.^1,2

Photochemotherapy with methoxsalen and high-intensity, long-wave UV radiation (black light) has recently been introduced as a treatment for psoriasis.³ In contrast to vitiligo patients, a majority of patients with psoriasis have been previously treated with potential carcinogens such as arsenic and x-ray or UV radiation.

We observed that treatment with methoxsalen and sunlight was followed by a development of multiple basal cell carcinomes in a patient who previously had been treated with arsenic for vitiligo.

Report of a Case.—

A 41-year-old woman who had had vitiligo since about 14 years of age was examined in our department for the first time in 1971. The patient had hitherto . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?